Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 |
Revenues | 69,785.0 | 64,388.0 | 56,587.0 | 45,349.0 | 34,701.0 | 66,501.0 | 59,837.0 | 57,244.0 |
Revenue growth | 8.4% | 13.8% | 24.8% | 30.7% | -42.0% | | 4.5% | 2.0% |
Cost of goods sold | 56,117.0 | 51,897.0 | 44,873.0 | 34,598.0 | 27,465.0 | 0.0 | 44,201.0 | 41,458.0 |
Gross profit | 13,668.0 | 12,491.0 | 11,714.0 | 10,751.0 | 7,236.0 | 66,501.0 | 15,636.0 | 15,786.0 |
Gross margin | 19.6% | 19.4% | 20.7% | 23.7% | 20.9% | 100.0% | 26.1% | 27.6% |
Selling, general and administrative | 5,663.0 | 5,224.0 | 5,540.0 | 3,711.0 | 2,864.0 | 0.0 | 6,429.0 | 5,958.0 |
Research and development | | 2,732.0 | 2,582.0 | 2,452.0 | 1,878.0 | | 2,427.0 | 2,376.0 |
EBITA | 5,414.0 | 7,397.0 | 3,419.0 | 6,158.0 | 3,613.0 | 8,553.0 | 8,972.0 | 9,012.0 |
EBITA margin | 7.8% | 11.5% | 6.0% | 13.6% | 10.4% | 12.9% | 15.0% | 15.7% |
Amortization of intangibles | | 2,439.0 | 2,125.0 | 1,244.0 | 736.0 | | 834.0 | 778.0 |
EBIT | 5,414.0 | 4,958.0 | 1,294.0 | 4,914.0 | 2,877.0 | 8,553.0 | 8,138.0 | 8,234.0 |
EBIT margin | 7.8% | 7.7% | 2.3% | 10.8% | 8.3% | 12.9% | 13.6% | 14.4% |
Pre-tax income | 6,027.0 | 4,931.0 | -2,353.0 | 4,152.0 | 2,504.0 | 8,280.0 | 7,763.0 | 7,133.0 |
Income taxes | 700.0 | 786.0 | 575.0 | 421.0 | 1,098.0 | 0.0 | 2,843.0 | 1,697.0 |
Tax rate | 11.6% | 15.9% | | 10.1% | 43.8% | 0.0% | 36.6% | 23.8% |
Earnings from continuing ops | 5,204.0 | 33.0 | 367.0 | -2,217.0 | -4,248.0 | 5,269.0 | 4,920.0 | 5,446.0 |
Earnings from discontinued ops | | -33.0 | -367.0 | 2,217.0 | 4,248.0 | | | -10.0 |
Net income | 5,204.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5,269.0 | 4,920.0 | 5,436.0 |
Net margin | 7.5% | 0.0% | 0.0% | 0.0% | 0.0% | 7.9% | 8.2% | 9.5% |
|
Diluted EPS | $3.50 | $21.88 | $270.29 | ($2,566.27) | ($5,243.80) | | $6.16 | $6.59 |
Shares outstanding (diluted) | 1,485.9 | 1.5 | 1.4 | 0.9 | 0.8 | | 799.1 | 826.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|